Literature DB >> 18271418

[Real-time three-dimensional (4D) ultrasound-guided prostatic biopsies on a phantom. Comparative study versus 2D guidance].

Jean-Alexandre Long1, Vincent Daanen, Alexandre Moreau-Gaudry, Jocelyne Troccaz, Jean-Jacques Rambeaud, Jean-Luc Descotes.   

Abstract

OBJECTIVE: The objective of this study was to determine the added value of real-time three-dimensional (4D) ultrasound guidance of prostatic biopsies on a prostate phantom in terms of the precision of guidance and distribution.
METHODS: A prostate phantom was constructed. A real-time 3D ultrasonograph connected to a transrectal 5.9 MHz volumic transducer was used. Fourteen operators performed 336 biopsies with 2D guidance then 4D guidance according to a 12-biopsy protocol. Biopsy tracts were modelled by segmentation in a 3D ultrasound volume. Specific software allowed visualization of biopsy tracts in the reference prostate and evaluated the zone biopsied. A comparative study was performed to determine the added value of 4D guidance compared to 2D guidance by evaluating the precision of entry points and target points. The distribution was evaluated by measuring the volume investigated and by a redundancy ratio of the biopsy points.
RESULTS: The precision of the biopsy protocol was significantly improved by 4D guidance (p = 0.037). No increase of the biopsy volume and no improvement of the distribution of biopsies were observed with 4D compared to 2D guidance.
CONCLUSION: The real-time 3D ultrasound-guided prostate biopsy technique on a phantom model appears to improve the precision and reproducibility of a biopsy protocol, but the distribution of biopsies does not appear to be improved.

Mesh:

Year:  2007        PMID: 18271418     DOI: 10.1016/s1166-7087(07)78573-1

Source DB:  PubMed          Journal:  Prog Urol        ISSN: 1166-7087            Impact factor:   0.915


  1 in total

1.  Development and Phantom Validation of a 3-D-Ultrasound-Guided System for Targeting MRI-Visible Lesions During Transrectal Prostate Biopsy.

Authors:  Yipeng Hu; Veeru Kasivisvanathan; Lucy A M Simmons; Matthew J Clarkson; Stephen A Thompson; Taimur T Shah; Hashim U Ahmed; Shonit Punwani; David J Hawkes; Mark Emberton; Caroline M Moore; Dean C Barratt
Journal:  IEEE Trans Biomed Eng       Date:  2016-06-21       Impact factor: 4.538

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.